Welcome to LookChem.com Sign In|Join Free

CAS

  • or

825621-06-5

Post Buying Request

825621-06-5 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

825621-06-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 825621-06-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,2,5,6,2 and 1 respectively; the second part has 2 digits, 0 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 825621-06:
(8*8)+(7*2)+(6*5)+(5*6)+(4*2)+(3*1)+(2*0)+(1*6)=155
155 % 10 = 5
So 825621-06-5 is a valid CAS Registry Number.

825621-06-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 11, 2017

Revision Date: Aug 11, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-(2-phenylethenyl)-2-[4-(2-phenylethenyl)pyridin-2-yl]pyridine

1.2 Other means of identification

Product number -
Other names 2,2'-Bipyridine,4,4'-bis[(1E)-2-phenylethenyl]

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:825621-06-5 SDS

825621-06-5Downstream Products

825621-06-5Relevant articles and documents

METAL COMPLEXES BEARING BISSTYRYL-BIPYRIDINE LIGAND AND THEIR USE AS PHOTOSENSITIZER AGENT IN ONE AND TWO-PHOTON PHOTODYNAMIC THERAPY

-

Page/Page column 49; 52, (2021/05/15)

The present invention relates to metal complexes bearing at least one (E-E')-4,4'- bisstyryl-2,2'-bipyridine ligand (LIG1) of the following formula (I): or a pharmaceutically acceptable salt and/or solvate thereof. The present invention also relates to pharmaceutical compositions comprising these complexes and at least one pharmaceutically acceptable excipient. The present invention also relates to the use of compounds of formula (I) or pharmaceutical compositions comprising thereof as drug and as photosensitizer agent in photodynamic therapy. The present invention also relates to methods of preparation of said complexes.

Rationally designed ruthenium complexes for 1- and 2-photon photodynamic therapy

Blacque, Olivier,Chao, Hui,Ciofini, Ilaria,Gasser, Gilles,Karges, Johannes,Kuang, Shi,Maschietto, Federica

, (2020/07/03)

The use of photodynamic therapy (PDT) against cancer has received increasing attention over recent years. However, the application of the currently approved photosensitizers (PSs) is limited by their poor aqueous solubility, aggregation, photobleaching an

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 825621-06-5